These bioinformatics findings suggest that high NAT10 expression in ccRCC is associated with ferroptosis inhibition through transcriptional regulation of key antioxidant and iron metabolism pathways (Figs. 3A–3C). The gene discussed is NAT10; the disease is nonpapillary renal cell carcinoma.